On Friday, Axogen Inc (NASDAQ: AXGN) was -4.60% drop from the session before settling in for the closing price of $13.27. A 52-week range for AXGN has been $4.83 – $15.90.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 13.87%. When this article was written, the company’s average yearly earnings per share was at 145.10%. With a float of $41.49 million, this company’s outstanding shares have now reached $43.12 million.
Considering the fact that the conglomerate employs 428 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 76.4%, operating margin of -4.7%, and the pretax margin is -7.91%.
Axogen Inc (AXGN) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Axogen Inc stocks. The insider ownership of Axogen Inc is 5.71%, while institutional ownership is 84.62%. The most recent insider transaction that took place on Nov 07 ’24, was worth 890,000. Before that another transaction happened on Sep 05 ’24, when Company’s SENIOR ADVISOR proposed sale 150,000 for $13.00, making the entire transaction worth $1,950,000.
Axogen Inc (AXGN) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 145.10% per share during the next fiscal year.
Axogen Inc (NASDAQ: AXGN) Trading Performance Indicators
You can see what Axogen Inc (AXGN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.47. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.33, a number that is poised to hit 0.03 in the next quarter and is forecasted to reach 0.31 in one year’s time.
Technical Analysis of Axogen Inc (AXGN)
Compared to the last year’s volume of 0.4 million, its volume of 0.72 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 48.23%. Additionally, its Average True Range was 0.91.
During the past 100 days, Axogen Inc’s (AXGN) raw stochastic average was set at 65.20%, which indicates a significant increase from 26.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 75.11% in the past 14 days, which was higher than the 71.05% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.80, while its 200-day Moving Average is $9.73. Nevertheless, the first resistance level for the watch stands at $13.25 in the near term. At $13.83, the stock is likely to face the second major resistance level. The third major resistance level sits at $14.30. If the price goes on to break the first support level at $12.20, it is likely to go to the next support level at $11.73. Now, if the price goes above the second support level, the third support stands at $11.15.
Axogen Inc (NASDAQ: AXGN) Key Stats
There are 43,830K outstanding shares of the company, which has a market capitalization of 531.53 million. As of now, sales total 159,010 K while income totals -21,720 K. Its latest quarter income was 47,910 K while its last quarter net income were -1,920 K.
